Interchangeable biosimilar approvals
RecordSTO-FGN4ATG281-3DKK24SP6N-6W5BDM
United States · 2024
Interchangeable biosimilar approvals in the United States were 9 in 2024 (FDA).
New drug approvals in United States: every year, the rank and how it is measured
- Publisher
- FDA
- Authority tier
- T1 Official
- Locator
- A Record Year for Biosimilar Approvals
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
Also in 2024, CDER approved 9 interchangeable biosimilars (for new and previously approved biosimilars).
Checked: the figure 9is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_FGN4ATG2813DKK24SP6N6W5BDM
Other formats: MLA, Chicago, BibTeX
- MLA
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024, https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_FGN4ATG2813DKK24SP6N6W5BDM.
- Chicago
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024. https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_FGN4ATG2813DKK24SP6N6W5BDM.
- BibTeX
- @misc{fda2024interchangeable6w5bdm, author = {{U.S. Food and Drug Administration}}, title = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_FGN4ATG2813DKK24SP6N6W5BDM}, note = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- U.S. Food and Drug Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024
- Type
- Press release
- Published
- —
- Locator
- A Record Year for Biosimilar Approvals
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_FGN4ATG2813DKK24SP6N6W5BDM